journal article·2016-02

Sodium alginate-functionalized nanodiamonds as sustained chemotherapeutic drug-release vectors

Zhifen Cui, Yu Zhang, Jichao Zhang, Huating Kong, Xiaoxing Tang, Liang Pan, Kai Xia, Ali Aldalbahi, Aiguo Li, Renzhong Tai, Chunhai Fan, Ying Zhu

Carbon· Volume 97
Publisher page

Abstract

Abstract Prolonged therapeutic action over an extended period of time on single dose is vital in designing an ideal drug delivery system. Nanoparticle-based vehicles for drug delivery serves as an ideal technology, however, utilization of them remains controversial due to potential safety concerns and transient drug retention. Nanodiamonds (NDs), with excellent biocompatibility and diversity of potential conjugates, have emerged as alternative promising materials in this regard. Here, we developed sodium alginate functionalized NDs (fNDs) for drug delivery. Cisplatin (DDP) was chosen as a model drug and coated on the negatively charged fNDs clusters. Our work demonstrated that fNDs were capable of enhancing drug accumulation and retention time in tumor cells, leading to continued tumor cell killing effect after clearance of drug treatment. Furthermore, fNDs–DDP treatment improved drug safety compared to DDP treatment. Thus, this new platform may have strong potential for further biomedical application.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Diamond and Carbon-based Materials Research · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Designing materials for biology and medicine10.1038/nature02388 ↗
2. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
3. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size10.1038/nnano.2011.166 ↗
4. Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
5. Functionalized carbon nanotubes in drug design and discovery10.1021/ar700089b ↗
6. Preparation and functionalization of graphene nanocomposites for biomedical applications10.1038/nprot.2013.146 ↗
7. Gold nanoparticles for biology and medicine10.1002/anie.200904359 ↗
8. A comparative evaluation of poly-l-lysine-palmitic acid and Lipofectamine (TM) 2000 for plasmid delivery to bone marrow stromal cells10.1016/j.biomaterials.2007.07.023 ↗
9. Physicochemical, cytotoxic, and dermal release features of a novel cationic liposome nanocarrier10.1002/adhm.201200302 ↗
10. Toxicology of carbon nanomaterials: Status, trends, and perspectives on the special issue10.1016/j.carbon.2005.12.023 ↗
11. Culture medium-associated physicochemical insights on cytotoxicity of carbon nanomaterials10.1021/tx500477y ↗
12. Multifunctional HER2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy10.1021/am406012g ↗
13. Preparation of the phycoerythrin subunit liposome in a photodynamic experiment on liver cancer cells10.1111/j.1745-7254.2008.00886.x ↗
14. Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells10.1186/1471-2407-9-351 ↗
15. Carbohydrate coated, folate functionalized colloidal graphene as a nanocarrier for both hydrophobic and hydrophilic drugs10.1039/c3nr05431d ↗
16. Dual-targeted nanocarrier based on cell surface receptor and intracellular mRNA: an effective strategy for cancer cell imaging and therapy10.1021/ac401405n ↗
17. On the history of the discovery of nanodiamond synthesis10.1134/1.1711431 ↗
18. Differential biocompatibility of carbon nanotubes and nanodiamonds10.1016/j.diamond.2007.07.020 ↗
19. The properties and applications of nanodiamonds10.1038/nnano.2011.209 ↗
20. The biocompatibility of nanodiamonds and their application in drug delivery systems10.7150/thno.3627 ↗
21. Polymer-functionalized nanodiamond platforms as vehicles for gene delivery10.1021/nn900865g ↗
22. Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy10.1002/adma.201102263 ↗
23. Excessive sodium ions delivered into cells by nanodiamonds: implications for tumor therapy10.1002/smll.201102539 ↗
24. Nanodiamonds act as Trojan horse for intracellular delivery of metal ions to trigger cytotoxicity10.1186/s12989-014-0075-z ↗
25. Active nanodiamond hydrogels for chemotherapeutic delivery10.1021/nl071521o ↗
26. Nanodiamond-mediated delivery of water-insoluble therapeutics10.1021/nn900480m ↗
27. Nanodiamonds as intracellular transporters of chemotherapeutic drug10.1016/j.biomaterials.2010.07.058 ↗
28. Cellular processing of platinum anticancer drugs10.1038/nrd1691 ↗
29. A multiplatform code for the analysis of energy-dispersive X-ray fluorescence spectra10.1016/j.sab.2006.12.002 ↗
30. Novel alginate coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of BSA10.1007/s10856-013-4977-3 ↗
31. Synthesis and antitumor activity of polyphosphazene/methoxy-poly(ethylene glycol)/(diamine)platinum(II) conjugates10.1295/polymj.31.1247 ↗
32. Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix10.1016/S0168-3659(03)00151-2 ↗
33. Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology10.1016/j.ijbiomac.2011.07.013 ↗
34. Imaging of the intracellular topography of copper with a fluorescent sensor and by synchrotron x-ray fluorescence microscopy10.1073/pnas.0406547102 ↗
35. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy10.1146/annurev.pharmtox.48.080907.180426 ↗
36. Cisplatin: a review of toxicities and therapeutic applications10.1111/j.1476-5829.2007.00142.x ↗
37. Nanotechnology applications in cancer10.1146/annurev.bioeng.9.060906.152025 ↗
38. Nanoparticle therapeutics: an emerging treatment modality for cancer10.1038/nrd2614 ↗
39. Is cisplatin-induced cell death always produced by apoptosis?10.1124/mol.59.4.657 ↗
40. Cisplatin: mode of cytotoxic action and molecular basis of resistance10.1038/sj.onc.1206933 ↗
41. Cisplatin stops tubulin assembly into microtubules. A new insight into the mechanism of antitumor activity of platinum complexes10.1016/S0141-8130(00)00159-8 ↗